Endpoints News 3. Feb. 2026 Ultragenyx unwraps data that may be central to its gene therapy resubmission
Endpoints News 3. Feb. 2026 Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings
Endpoints News 3. Feb. 2026 Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months
Endpoints News 2. Feb. 2026 First 10 Medicare-negotiated drug prices have taken effect: Are seniors really saving money?
Endpoints News 2. Feb. 2026 Spring Health acquires Alma, expanding insurance reach in virtual mental health
Endpoints News 2. Feb. 2026 European law changes mean drugmakers may have to grapple with generic competition sooner
Endpoints News 31. Jan. 2026 Big Pharma earnings kick off; Third-round IRA drugs selected; Hengrui’s trailblazing moment; and more
Endpoints News 30. Jan. 2026 FDA says it explained issues early on for Corcept's rejected Cushing's syndrome drug